These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24725156)

  • 1. Charge clamps of lysines and hydrogen bonds play key roles in the mechanism to fix helix 12 in the agonist and antagonist positions of estrogen receptor α: intramolecular interactions studied by the ab initio fragment molecular orbital method.
    Watanabe C; Fukuzawa K; Tanaka S; Aida-Hyugaji S
    J Phys Chem B; 2014 May; 118(19):4993-5008. PubMed ID: 24725156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation helix orientation of the estrogen receptor is mediated by receptor dimerization: evidence from molecular dynamics simulations.
    Fratev F
    Phys Chem Chem Phys; 2015 May; 17(20):13403-20. PubMed ID: 25927714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L; Lund JD; Schiøtt B
    Biochemistry; 2007 Feb; 46(7):1743-58. PubMed ID: 17249692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into Resveratrol's antagonist and partial agonist actions on estrogen receptor alpha.
    Chakraborty S; Levenson AS; Biswas PK
    BMC Struct Biol; 2013 Oct; 13():27. PubMed ID: 24160181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simulations reveal increased fluctuations in estrogen receptor-alpha conformation upon antagonist binding.
    Ng HL
    J Mol Graph Model; 2016 Sep; 69():72-7. PubMed ID: 27580485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ab initio quantum mechanical study of the binding energies of human estrogen receptor alpha with its ligands: an application of fragment molecular orbital method.
    Fukuzawa K; Kitaura K; Uebayasi M; Nakata K; Kaminuma T; Nakano T
    J Comput Chem; 2005 Jan; 26(1):1-10. PubMed ID: 15521089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenicity of halogenated bisphenol A: in vitro and in silico investigations.
    Zhang J; Li T; Wang T; Yuan C; Zhong S; Guan T; Li Z; Wang Y; Yu H; Luo Q; Wang Y; Zhang T
    Arch Toxicol; 2018 Mar; 92(3):1215-1223. PubMed ID: 29152682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ab initio fragment molecular orbital study of molecular interactions in liganded retinoid X receptor: specification of residues associated with ligand inducible information transmission.
    Ito M; Fukuzawa K; Ishikawa T; Mochizuki Y; Nakano T; Tanaka S
    J Phys Chem B; 2008 Sep; 112(38):12081-94. PubMed ID: 18729504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted mutation of key residues at the start of helix 12 in the hERalpha ligand-binding domain identifies the role of hydrogen-bonding and hydrophobic interactions in the activity of the protein.
    Zhao C; Abrams J; Skafar DF
    J Steroid Biochem Mol Biol; 2006 Jan; 98(1):1-11. PubMed ID: 16191480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ab initio fragment molecular orbital study of molecular interactions between liganded retinoid X receptor and its coactivator: roles of helix 12 in the coactivator binding mechanism.
    Ito M; Fukuzawa K; Mochizuki Y; Nakano T; Tanaka S
    J Phys Chem B; 2007 Apr; 111(13):3525-33. PubMed ID: 17388485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the human estrogen receptor-alpha using targeted mutagenesis.
    Skafar DF; Koide S
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):83-90. PubMed ID: 16442702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the in Vitro Thermal Stability and Conformational Flexibility of Estrogen Receptors as Potential Key Factors of Their in Vivo Activity.
    Le Grand A; André-Leroux G; Marteil G; Duval H; Sire O; Le Tilly V
    Biochemistry; 2015 Jun; 54(25):3890-900. PubMed ID: 26029980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
    Nose T; Tokunaga T; Shimohigashi Y
    Toxicol Lett; 2009 Dec; 191(1):33-9. PubMed ID: 19666091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three- and four-body corrected fragment molecular orbital calculations with a novel subdividing fragmentation method applicable to structure-based drug design.
    Watanabe C; Fukuzawa K; Okiyama Y; Tsukamoto T; Kato A; Tanaka S; Mochizuki Y; Nakano T
    J Mol Graph Model; 2013 Apr; 41():31-42. PubMed ID: 23467020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the antagonistic action of diarylheptanoid on human estrogen receptor alpha.
    Geetha Rani Y; Lakshmi BS
    J Biomol Struct Dyn; 2019 Mar; 37(5):1189-1203. PubMed ID: 29557271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of regions within the F domain of the human estrogen receptor alpha that are important for modulating transactivation and protein-protein interactions.
    Koide A; Zhao C; Naganuma M; Abrams J; Deighton-Collins S; Skafar DF; Koide S
    Mol Endocrinol; 2007 Apr; 21(4):829-42. PubMed ID: 17185393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of a powerful capping motif corresponding to start of "helix 12" in agonist-bound estrogen receptor-alpha contributes to increased constitutive activity of the protein.
    Skafar DF
    Cell Biochem Biophys; 2000; 33(1):53-62. PubMed ID: 11322512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of a mutant hERalpha ligand-binding domain reveals key structural features for the mechanism of partial agonism.
    Gangloff M; Ruff M; Eiler S; Duclaud S; Wurtz JM; Moras D
    J Biol Chem; 2001 May; 276(18):15059-65. PubMed ID: 11278577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of Agonist and Antagonist Dynamic Binding Patterns in ER-α by Integration of Molecular Docking, Molecular Dynamics Simulations and Quantum Mechanical Calculations.
    Sakkiah S; Selvaraj C; Guo W; Liu J; Ge W; Patterson TA; Hong H
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
    Métivier R; Penot G; Flouriot G; Pakdel F
    Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.